Gilead announces date ‘to release financial data’

Gilead has declared a date it will release its fourth quarter and year end 2008 financial results.

Scheduled for January 27th, the announcement of the data will be accompanied by a conference call live on the company’s website, which will be led by its management.

In the call, the executives will discuss Gilead’s financial results, along with presenting a business update and financial guidance for the year ahead.

The company went on to note the webcast will be available on the website for one year afterwards.

Last month, the organisation said it was to sue Teva, over the infringement of US patent numbers 6,642,245 and 6,703,396.

The rights are licensed exclusively to the company and are associated with emtricitabine, a component of Truvada – a therapy for HIV-1 infection in adults.

Gilead’s lawsuit follows an Abbreviated New Drug Application filed by Teva, which sought to market a generic version of the drug.

In a press release, the company said: “Gilead has full confidence in the strength of its patent position and plans to vigorously defend the intellectual property rights of Truvada.”